Extralia Labs

Extralia Labs is a French biotechnology company specializing in cellular rejuvenation and the reversal of biological aging. The company leverages pioneering research in cellular reprogramming to develop therapies that reset the epigenetic state of cells, effectively restoring youthful functionality. Their primary focus is on treating age-related pathologies, with a particular emphasis on neurodegenerative diseases and systemic frailty. By utilizing a proprietary platform based on Yamanaka factors and other rejuvenation molecules, Extralia Labs aims to extend human healthspan and provide novel solutions for chronic conditions associated with aging. The company is a spin-off from leading French research institutions, combining academic excellence with therapeutic development.